| Announce Date | 01/07/2026 |
| EPS Normalized Actual | $0.72 (Beat by $0.05) |
| EPS GAAP Actual | $0.72 (Beat by $0.05) |
| Revenue Actual | $19.1237B |
| Revenue Surprise | Beat by $19123.7M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Feb 2030 | 2.16 | 8.6 | 2.13473 | 2.18617 | 1 |
| Feb 2030 | 2.17 | 8.56 | 2.1314 | 2.19989 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 0.55 | 0.55 | 19.1237B | 1.83% | 19123.7M |
| FQ3 2025 (Sep 2025) | 0.3 | 0.3 | 18.9158B | 100% | 18915.8M |
| FQ2 2025 (Jun 2025) | 0.41 | 0.41 | 24.8808B | 100% | 24880.8M |
| FQ1 2025 (Feb 2025) | 0 | 0 | 18.7995B | 100% | 18799.5M |
| FQ4 2024 (Nov 2024) | 0.69 | 0.69 | 18.7745B | 100% | 18774.5M |
| FQ2 2014 (May 2014) | -0.21 | -0.21 | 7.2117B | 100% | 7211.7M |
| FQ3 2014 (Aug 2014) | -0.15 | -0.15 | 5.6099B | 100% | 5609.9M |
| FQ4 2014 (Nov 2014) | -0.41 | -0.41 | 5.5796B | 100% | 5579.6M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2031 (May 2031) | 0.59 | -- | 0.58122 | 0.59548 | 6 |
| FQ1 2031 (Feb 2031) | 0.88 | -- | 0.8669 | 0.88817 | 6 |
| FQ4 2030 (Nov 2030) | 0.53 | -- | 0.52211 | 0.53492 | 8 |
| FQ3 2030 (Aug 2030) | 0.69 | -- | 0.67973 | 0.6964 | 8 |
| FQ2 2030 (May 2030) | 0.47315 | -- | 0.46611 | 0.47754 | 8 |
| FQ1 2030 (Mar 2030) | 0.75306 | -- | 0.73372 | 0.76068 | 4 |
| FQ4 2029 (Nov 2029) | 0.48478 | -- | 0.47756 | 0.48928 | 5 |
| FQ3 2029 (Aug 2029) | 0.58754 | -- | 0.57879 | 0.59299 | 5 |
| FQ2 2029 (May 2029) | 0.48046 | -- | 0.47331 | 0.48492 | 5 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2031 (May 2031) | 19.91B | -- | 19.69B | 20.06B | 3 |
| FQ1 2031 (Feb 2031) | 19.97B | -- | 19.74B | 20.11B | 3 |
| FQ4 2030 (Nov 2030) | 19.5B | -- | 19.28B | 19.64B | 4 |
| FQ3 2030 (Aug 2030) | 25.54B | -- | 25.24B | 25.72B | 6 |
| FQ2 2030 (May 2030) | 19.59B | -- | 19.37B | 19.73B | 4 |
| FQ1 2030 (Mar 2030) | 19.6B | -- | 19.21B | 19.75B | 5 |
| FQ4 2029 (Nov 2029) | 19.28B | -- | 19.06B | 19.42B | 8 |
| FQ3 2029 (Aug 2029) | 25.28B | -- | 24.99B | 25.46B | 5 |
| FQ2 2029 (May 2029) | 20.6B | -- | 20.37B | 20.75B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
3
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 0.55 | 0.55 | 100% | |
| FQ3 2025 (Sep 2025) | 0.3 | 0.3 | 100% | |
| FQ2 2025 (Jun 2025) | 0.41 | 0.41 | 100% | |
| FQ1 2025 (Feb 2025) | 0 | 0 | NAN% | |
| FQ4 2024 (Nov 2024) | 0.69 | 0.69 | 100% | |
| FQ2 2014 (May 2014) | -0.21 | -0.21 | 100% | |
| FQ3 2014 (Aug 2014) | -0.15 | -0.15 | 100% | |
| FQ4 2014 (Nov 2014) | -0.41 | -0.41 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | $0B | $19.12B | $19123.7M | 100% |
| FQ3 2025 (Sep 2025) | $0B | $18.92B | $18915.8M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $24.88B | $24880.8M | 100% |
| FQ1 2025 (Feb 2025) | $0B | $18.8B | $18799.5M | 100% |
| FQ4 2024 (Nov 2024) | $0B | $18.77B | $18774.5M | 100% |
| FQ2 2014 (May 2014) | $0B | $7.21B | $7211.7M | 100% |
| FQ3 2014 (Aug 2014) | $0B | $5.61B | $5609.9M | 100% |
| FQ4 2014 (Nov 2014) | $0B | $5.58B | $5579.6M | 100% |